NCT07600541 Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine
| NCT ID | NCT07600541 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Paris Translational Research Center for Organ Transplantation |
| Condition | Kidney Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2026-04-15 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.
Eligibility Criteria
* Inclusion criteria * Age ≥ 18 years * Fluency in French or English * Electronic consent given * Exclusion criteria * Severe cognitive impairment preventing comprehension * Technical inability to access the questionnaire
Frequently Asked Questions
Who can join the NCT07600541 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07600541 currently recruiting?
Yes, NCT07600541 is actively recruiting participants. Visit ClinicalTrials.gov or contact Paris Translational Research Center for Organ Transplantation to inquire about joining.
Where is the NCT07600541 trial being conducted?
This trial is being conducted at Paris, France, Paris, France.
Who is sponsoring the NCT07600541 clinical trial?
NCT07600541 is sponsored by Paris Translational Research Center for Organ Transplantation. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.